A phase II neoadjuvant trial of concurrent trastuzumab and aromatase inhibitor in postmenopausal women with HER2-positive and hormone receptor-positive breast cancer.
Phase of Trial: Phase II
Latest Information Update: 12 May 2016
At a glance
- Drugs Letrozole (Primary) ; Trastuzumab (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- 13 Oct 2012 Status changed from not stated to recruiting as reported by University Hospital Medical Information Network - Japan record.
- 28 Feb 2012 New trial record